Published in J Clin Endocrinol Metab on June 01, 2004
Effects of the Atkins Diet Versus a Low Fat Diet on Inflammation | NCT00993278
Paediatric Obesity and Cardiovascular Dysfunction | NCT03169257
Non Alcoholic Steatohepatitis in Relation to Visceral and Subcutaneous Fat | NCT04240145
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 9.49
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol (2008) 8.43
Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature (2010) 5.01
An emerging role of mTOR in lipid biosynthesis. Curr Biol (2009) 3.50
Gender differences in insulin resistance, body composition, and energy balance. Gend Med (2009) 3.19
Emerging role of adipose tissue hypoxia in obesity and insulin resistance. Int J Obes (Lond) (2008) 3.17
PPAR delta: a dagger in the heart of the metabolic syndrome. J Clin Invest (2006) 3.17
Cardiac remodeling in obesity. Physiol Rev (2008) 2.95
Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest (2007) 2.73
Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice. Hepatology (2005) 2.72
Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes (2011) 2.67
Obesity and free fatty acids. Endocrinol Metab Clin North Am (2008) 2.64
Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A (2005) 2.63
Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab (2007) 2.58
Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res (2010) 2.49
The metabolic syndrome: A high-risk state for cancer? Am J Pathol (2006) 2.46
Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) (2010) 2.42
Changes in body composition in women over six years at midlife: ovarian and chronological aging. J Clin Endocrinol Metab (2006) 2.40
Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res (2008) 2.40
Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes (2010) 2.30
A comprehensive definition for metabolic syndrome. Dis Model Mech (2009) 2.23
Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol (2007) 2.17
Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci (2010) 2.16
Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest (2006) 2.09
Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem (2008) 2.08
eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab (2009) 2.04
Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann N Y Acad Sci (2012) 2.04
Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci (2014) 2.03
Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab (2008) 2.03
Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One (2008) 2.02
The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol (2008) 2.00
Caloric restriction and aging: studies in mice and monkeys. Toxicol Pathol (2008) 1.93
Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell (2005) 1.91
Behavioural treatments for chronic systemic inflammation: effects of dietary weight loss and exercise training. CMAJ (2005) 1.90
Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis (2009) 1.84
Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes (2011) 1.82
The impact of maternal obesity on maternal and fetal health. Rev Obstet Gynecol (2008) 1.82
Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci (2010) 1.82
L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res (2008) 1.80
Preterm birth, infant weight gain, and childhood asthma risk: a meta-analysis of 147,000 European children. J Allergy Clin Immunol (2014) 1.79
Pancreatic function, type 2 diabetes, and metabolism in aging. Int J Endocrinol (2012) 1.77
Childhood obesity and asthma control in the GALA II and SAGE II studies. Am J Respir Crit Care Med (2013) 1.75
Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study. BMC Pediatr (2010) 1.72
Nuclear receptors, mitochondria and lipid metabolism. Mitochondrion (2008) 1.71
Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) (2010) 1.71
Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Des Devel Ther (2011) 1.68
Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ (2012) 1.64
Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci U S A (2006) 1.63
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2007) 1.61
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab (2007) 1.61
Non-invasive means of measuring hepatic fat content. World J Gastroenterol (2008) 1.60
Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol (2012) 1.59
Chronic maternal dietary chromium restriction modulates visceral adiposity: probable underlying mechanisms. Diabetes (2009) 1.58
IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes (2007) 1.56
Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res (2012) 1.55
Influence of exercise and perivascular adipose tissue on coronary artery vasomotor function in a familial hypercholesterolemic porcine atherosclerosis model. J Appl Physiol (1985) (2009) 1.53
Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control (2009) 1.52
Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes. BMC Biol (2009) 1.51
Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA (2013) 1.51
The Secreted Enzyme PM20D1 Regulates Lipidated Amino Acid Uncouplers of Mitochondria. Cell (2016) 1.49
Nonalcoholic fatty liver disease. J Lipid Res (2008) 1.47
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One (2012) 1.41
Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc Diabetol (2009) 1.38
Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int (2007) 1.38
The relationship of omental and subcutaneous adipocyte size to metabolic disease in severe obesity. PLoS One (2010) 1.37
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest (2016) 1.37
Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation. Am J Epidemiol (2009) 1.36
PGC-1alpha in aging and anti-aging interventions. Biochim Biophys Acta (2009) 1.35
Obesity and immune cell counts in women. Metabolism (2007) 1.31
Does the amount of fat mass predict age-related loss of lean mass, muscle strength, and muscle quality in older adults? J Gerontol A Biol Sci Med Sci (2011) 1.30
Perivascular adipose tissue: more than just structural support. Clin Sci (Lond) (2012) 1.29
Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26
Mechanisms of insulin resistance in obesity. Front Med (2013) 1.26
Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes (2009) 1.25
The renin angiotensin system and the metabolic syndrome. Physiol Behav (2010) 1.25
Relationship of fat distribution with adipokines in human immunodeficiency virus infection. J Clin Endocrinol Metab (2007) 1.24
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat (2011) 1.24
New roles of carboxypeptidase E in endocrine and neural function and cancer. Endocr Rev (2012) 1.23
Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. J Clin Endocrinol Metab (2010) 1.21
Immune regulation of metabolic homeostasis in health and disease. Cell (2015) 1.21
Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement (2012) 1.21
Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue. Diabetes (2009) 1.20
Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls. J Clin Endocrinol Metab (2008) 1.20
Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg (2009) 1.20
Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci (2007) 1.19
Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements. Pediatr Res (2016) 1.19
Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur J Med Res (2013) 1.19
Mechanisms of obesity-induced gastrointestinal neoplasia. Gastroenterology (2013) 1.18
Optimal body weight for health and longevity: bridging basic, clinical, and population research. Aging Cell (2014) 1.16
Targeting orphan nuclear receptors for treatment of metabolic diseases and autoimmunity. Chem Biol (2012) 1.16
Resistance to high-fat diet-induced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy. Diabetes (2008) 1.16
Regulation of energy metabolism by inflammation: a feedback response in obesity and calorie restriction. Aging (Albany NY) (2010) 1.16
Deterioration of insulin sensitivity and beta-cell function in overweight Hispanic children during pubertal transition: a longitudinal assessment. Int J Pediatr Obes (2006) 1.15
Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control (2008) 1.15
Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metab (2008) 1.13
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol (2011) 1.12
Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm (2013) 1.11
Longitudinal changes in intermuscular fat volume and quadriceps muscle volume in the thighs of women with knee osteoarthritis. Arthritis Care Res (Hoboken) (2012) 1.11
Identification and validation of novel adipokines released from primary human adipocytes. Mol Cell Proteomics (2011) 1.10
Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev (2013) 1.10
TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest (2006) 17.49
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab (2007) 9.34
FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev (2012) 5.71
Leptin regulation of the mesoaccumbens dopamine pathway. Neuron (2006) 4.53
Region-specific leptin resistance within the hypothalamus of diet-induced obese mice. Endocrinology (2004) 4.10
Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science (2005) 4.01
Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes (2010) 3.30
Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med (2004) 2.98
Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology (2009) 2.89
Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes (2007) 2.54
Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab (2006) 2.52
Adipose triglyceride lipase: function, regulation by insulin, and comparison with adiponutrin. Diabetes (2006) 2.50
The gut and energy balance: visceral allies in the obesity wars. Science (2005) 2.24
Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes (2004) 2.12
Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem (2004) 2.11
The adipocyte as an active participant in energy balance and metabolism. Gastroenterology (2007) 2.02
Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo. Endocrinology (2011) 2.00
Evidence for constitutive neural cell proliferation in the adult murine hypothalamus. J Comp Neurol (2007) 1.96
Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMC-expressing cells. Cell Metab (2006) 1.96
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest (2003) 1.95
Remodeling of the arcuate nucleus energy-balance circuit is inhibited in obese mice. J Clin Invest (2011) 1.89
Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice. Proc Natl Acad Sci U S A (2008) 1.83
Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem (2004) 1.75
Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling. J Biol Chem (2009) 1.63
Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metab (2007) 1.63
PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab (2007) 1.61
Transplanted hypothalamic neurons restore leptin signaling and ameliorate obesity in db/db mice. Science (2011) 1.60
Evolution in health and medicine Sackler colloquium: Making evolutionary biology a basic science for medicine. Proc Natl Acad Sci U S A (2009) 1.45
Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype. Proc Natl Acad Sci U S A (2003) 1.41
Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes (2005) 1.40
Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes (2002) 1.37
Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology (2002) 1.36
Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem (2006) 1.35
Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts. Proc Natl Acad Sci U S A (2007) 1.35
Neuroscience. The fat-brain axis enters a new dimension. Science (2004) 1.33
Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes (2006) 1.30
Selective inactivation of Socs3 in SF1 neurons improves glucose homeostasis without affecting body weight. Endocrinology (2008) 1.29
Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha. Diabetes (2002) 1.29
Regulation of melanocortin-4 receptor signaling: agonist-mediated desensitization and internalization. Endocrinology (2003) 1.22
Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner. J Biol Chem (2010) 1.16
The stomach speaks--ghrelin and weight regulation. N Engl J Med (2002) 1.09
Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord (2003) 1.03
Creating a Nobel culture. Science (2013) 0.96
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2. Diabetes (2003) 0.94
Ciliary neurotrophic factor and leptin induce distinct patterns of immediate early gene expression in the brain. Diabetes (2004) 0.93
Reduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B. Endocrinology (2009) 0.91
Polymerase I and transcript release factor regulates lipolysis via a phosphorylation-dependent mechanism. Diabetes (2011) 0.90
A good night's sleep: future antidote to the obesity epidemic? Ann Intern Med (2004) 0.84
Physiology: is brain sympathetic to bone? Nature (2002) 0.80
Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo. Endocrinology (2014) 0.80